UMass Memorial Secures Approval for $54 Million Cancer Facility

The Massachusetts Public Health Council has approved UMass Memorial Health’s proposal to construct a $54 million cancer care facility in Marlborough. This state-of-the-art center will provide proton therapy, a modern alternative to traditional radiation therapy, enhancing treatment options for local patients.

The facility aims to address a significant gap in cancer treatment accessibility in Central Massachusetts. Currently, patients needing proton therapy must travel to the Proton Therapy Center at Massachusetts General Hospital in Boston or even journey to facilities in New York due to the limited availability of this advanced treatment in the region. The new center is expected to alleviate this burden.

Advancements in Cancer Treatment

Proton therapy uses a beam of charged protons to precisely target tumors. Unlike conventional radiation therapy, which often affects surrounding healthy tissues, proton therapy minimizes collateral damage, making it particularly beneficial for vulnerable populations, such as children. Shelly Hazlett, a spokesperson for UMass Memorial, emphasized the necessity of this facility in light of increasing cancer cases, stating, “As the incidence of cancer cases rises in Central Massachusetts and throughout the state, we’re committed to remaining a leader in clinical innovation.”

Currently, the only two proton therapy units in New England are located at Massachusetts General Hospital, treating approximately 640 patients annually. The anticipated UMass Memorial facility will not only increase access but is also part of a broader trend in Massachusetts, with Dana-Farber Cancer Institute planning a similar $50 million proton therapy center in Boston’s Longwood neighborhood.

Addressing the Unmet Need

Dr. Allison O’Neill, vice president for clinical performance management at Dana-Farber, noted the existing demand, saying, “There’s currently an unmet need.” This sentiment reflects a growing recognition of the importance of advanced treatment options in the fight against cancer.

While proponents advocate for the advantages of proton therapy, critics have raised questions regarding its cost-effectiveness. The therapy is typically more expensive than traditional methods, and ongoing studies are evaluating whether its benefits justify the higher investment. Nevertheless, UMass Memorial leaders assert that advancements in technology have contributed to a reduction in costs, potentially making proton therapy a more viable option for patients.

Furthermore, they argue that proton therapy may ultimately lead to lower overall expenses by decreasing the need for follow-up care and improving patients’ quality of life. As the project moves forward, it is expected to play a crucial role in enhancing cancer treatment accessibility and outcomes in the region.